Eleni Palpatzis

Eleni Palpatzis

Auto-generated profile, based on publicly available information

Eleni Palpatzis

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona Spain

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2021 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
EPEleni Palpatzis
Eleni Palpatzis
NBNick Bass
Nick Bass
RJRebecca Jones
Rebecca Jones
NMNaaheed Mukadam
Naaheed Mukadam

9 October 2024 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
CVClara Vila-Castelar
Clara Vila-Castelar
MAMuge Akinci
Muge Akinci
EPEleni Palpatzis
Eleni Palpatzis
PAPablo Aguilar-Dominguez
Pablo Aguilar-Dominguez
GOGregory Operto
Gregory Operto
EAEider M. Arenaza-Urquijo
Eider M. Arenaza-Urquijo
Glial reactivity may contribute to sex/gender differences in Alzheimer’s disease (AD) pathophysiology. Here, we investigated the differential effect of cerebrospinal fluid (CSF) glial markers on AD pathology and neurodegeneration by sex/gender among cognitively unimpaired older adults at increased risk of developing AD. We included 397 participants from the ALFA+ cohort with CSF Aβ42/40, p-tau181, sTREM2, YKL40, and GFAP, magnetic resonance imaging-based hippocampal volume (n = 299), and amyloid burden (centiloids) measured with [18F] flutemetamol positron emission tomography (n = 341). We ran multiple linear regression models to assess the association between glial markers, AD pathology and hippocampal volumes and their interaction with sex/gender, using False Discovery Rate to correct for multiple comparisons. Glial markers significantly contributed to explain amyloid burden, tau pathology, and hippocampal volumes, beyond age and/or primary AD pathology in a sex/gender-specific manner. Compared to men, women showed increased amyloid burden (centiloids) and CSF p-tau181 with increasing levels of sTREM2 and YKL40, and YKL40 and GFAP, respectively. Compared to women, men with greater tau burden showed lower hippocampal volumes as CSF YKL40 levels increased. Overall, our findings suggest that glial reactivity may contribute to sex/gender differences in AD progression, mostly, downstream amyloid. Further research identifying sex/gender-specific temporal dynamics in AD development is warranted to inform clinical trials.

11 March 2024 in Annals of Neurology
Verified
Journal Article
Open access
EPEleni Palpatzis
Eleni Palpatzis
MAMuge Akinci
Muge Akinci
PAPablo Aguilar‐Dominguez
Pablo Aguilar‐Dominguez
MGMarina Garcia‐Prat
Marina Garcia‐Prat
KBKaj Blennow
Kaj Blennow
FSfor the ALFA study
for the ALFA study
Objective: Along with the known effects of stress on brain structure and inflammatory processes, increasing evidence suggest a role of chronic stress in the pathogenesis of Alzheimer's disease (AD). We investigated the association of accumulated stressful life events (SLEs) with AD pathologies, neuroinflammation, and gray matter (GM) volume among cognitively unimpaired (CU) individuals at heightened risk of AD.Methods: This cross‐sectional cohort study included 1,290 CU participants (aged 48–77) from the ALFA cohort with SLE, lumbar puncture (n = 393), and/or structural magnetic resonance imaging (n = 1,234) assessments. Using multiple regression analyses, we examined the associations of total SLEs with cerebrospinal fluid (1) phosphorylated (p)‐tau181 and Aβ1–42/1–40 ratio, (2) interleukin 6 (IL‐6), and (3) GM volumes voxel‐wise. Further, we performed stratified and interaction analyses with sex, history of psychiatric disease, and evaluated SLEs during specific life periods.Results: Within the whole sample, only childhood and midlife SLEs, but not total SLEs, were associated with AD pathophysiology and neuroinflammation. Among those with a history of psychiatric disease SLEs were associated with higher p‐tau181 and IL‐6. Participants with history of psychiatric disease and men, showed lower Aβ1–42/1–40 with higher SLEs. Participants with history of psychiatric disease and women showed reduced GM volumes in somatic regions and prefrontal and limbic regions, respectively.Interpretation: We did not find evidence supporting the association of total SLEs with AD, neuroinflammation, and atrophy pathways. Instead, the associations appear to be contingent on events occurring during early and midlife, sex and history of psychiatric disease. ANN NEUROL 2024;95:1058–1068

31 July 2025 in The Journal Of Prevention of Alzheimer's Disease
Verified
Journal Article
Open access
PAPablo Aguilar-Dominguez
Pablo Aguilar-Dominguez
EPEleni Palpatzis
Eleni Palpatzis
MAMuge Akinci
Muge Akinci
ACAnna Canal-Garcia
Anna Canal-Garcia
JPJoana B. Pereira
Joana B. Pereira
EAEider M. Arenaza-Urquijo
Eider M. Arenaza-Urquijo
Psychiatric symptoms are increasingly recognized as early manifestations of Alzheimer's disease (AD). These symptoms may reflect or contribute to underlying neurobiological changes, including tau burden, which represents more advanced AD pathology. Understanding factors associated with tau burden may help identify individuals at elevated risk and improve early detection strategies. To investigate the temporal relationships between neuropsychiatric symptoms, demographic factors, and tau burden, by examining amyloid (Aβ)-dependent, -independent, and interactive associations. Retrospective cohort study. Alzheimer's Disease Neuroimaging Initiative. We included 681 participants without dementia (mean age = 71.2 years, 51.8 % female). The participants underwent tau PET scanning with prior amyloid PET and Neuropsychiatric Inventory (NPI) interview assessments clustered around three time periods relative to tau PET: closest (0 - 2 years), mid (3 - 5 years), and furthest (6 - 8 years). Linear regression analyses, adjusting for age and APOE ε4 alleles, examined associations of NPI scores, sex, education, and their Aβ-status interactions with tau burden. Higher total NPI scores up to 2 years prior to tau PET were associated with greater tau burden independently of Aβ status, whereas anxiety symptoms demonstrated an Aβ-dependent relationship with tau. (NPI: β=0.117, 95 % CI: 0.049 to 0.185, p=0.001, Anxiety: β=0.249, 95 % CI: 0.073 to 0.424, p=0.006). NPI measured up to 5 years prior to tau PET interacted with Aβ on tau burden (0-2 years: β=0.272, 95 % CI: 0.136 to 0.407, p<0.001, 3-5 years: β=0.336, 95 % CI: 0.127 to 0.544, p=0.002). Sex and education showed minimal associations with tau at uncorrected statistical levels. Neuropsychiatric symptoms were associated with tau burden up to two years before tau sampling, independently of Aβ, and interacted with Aβ status up to five years prior, suggesting that neuropsychiatric symptoms are related to tau in the short term and may represent manifestations of advancing AD pathology. Demographic factors showed minimal associations. These findings highlight the importance of evaluating neuropsychiatric and anxiety symptoms as potential indicators of increased tau pathology.

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
CPCleofé Peña‐Gomez
Cleofé Peña‐Gomez
MAMuge Akinci
Muge Akinci
PYPeter Young
Peter Young
FÖFredrik Öhman
Fredrik Öhman
EPEleni Palpatzis
Eleni Palpatzis
MSMichael Schöll
Michael Schöll
Background: Medial temporal lobe structures are particularly vulnerable in age‐related neurodegenerative diseases. Here, we investigated the brain reorganization that allows maintaining relatively normal global cognitive functioning in patients with herpes simplex encephalitis (HSE) – an infectious neurological disease ‐ with marked focal atrophy most pronounced in the medial temporal lobes, particularly the hippocampus. Using rs‐fMRI we (i) characterized the patterns of functional network organization, and (ii) compared the intra‐/interhemispheric functional connectivity (FC) within each patient.Method: A total of nine HSE patients were included (see Table 1), four of them were affected mainly in the left (LH) and five in the right (RH) hemisphere. The rs‐fMRI data were acquired after a long‐term follow‐up (median 16 years) of the disease and were preprocessed using the AFNI software. For each patient, using different brain parcellations, we computed the intra‐ and inter‐FC strength for each hemisphere separately, yielding four measures of intra‐FC LH/RH and inter‐FC LH/RH . We grouped the subjects according to their lesion‐side and their performance (low, high) in a memory task.Result: We observed, regardless of the lesion side, a highly variable pattern of disrupted FC in each patient. Left‐lesioned patients showed high intra‐FCLH/RH particularly in the precuneus/posterior cingulate (PPC) and the angular gyrus while right‐lesioned patients exhibited a high inter‐FCRH in the medial prefrontal cortex (MPFC) and PPC regions. Both left and right‐lesioned showed decreased intra‐FCLH/RH in ventral medial temporal areas, more pronounced in the left‐lesioned patients (Figure1). Right‐lesioned individuals who showed a pattern of inter‐FC within the right MPF and PPC performed consistently higher on the memory task (percentiles > 50) (Figure2).Conclusion: The substantial HSE‐induced medial temporal lobe lesions induce a global network reorganization. However, the side of the lesion seems to determine a specific pattern of network reorganization that is associated with differential cognitive performance. Left‐lesioned patients exhibited high PPC intra‐ and inter‐FCLH/RH and low memory performance while the right‐lesioned exhibited a high inter‐FCRH on the PPC and MPFC and better memory performance. Left lesions may result in nonadaptive brain reorganizations, however, right lesions, when linked to prefrontal brain reorganizations, may result in cognitive benefits and therefore be adaptive.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
MAMuge Akinci
Muge Akinci
CVClara Vila-Castelar
Clara Vila-Castelar
EPEleni Palpatzis
Eleni Palpatzis
GAGeorgette Argiris
Georgette Argiris
GKGwendlyn Kollmorgen
Gwendlyn Kollmorgen
EAEider M Arenaza‐Urquijo
Eider M Arenaza‐Urquijo
Background: Sex‐specific vulnerability and resilience along the amyloid cascade may be partly explained by neuroinflammatory processes. Microglial activation may play a more important role in the development of Alzheimer’s disease (AD) in women than in men. We investigated the effect of sex and biomarkers of microglia and astrocytic activation on amyloid (A) and tau (T) burden, and neurodegeneration (N) in cognitively unimpaired (CU) older adults at increased AD risk.Method: We included 397 CU participants (49‐73 years, 61.5% women) with the following available CSF biomarker data: Aβ42/40, p‐tau181, sTREM2, GFAP, and YKL40 measured with Roche NeuroToolKit or Elecsys® immunoassays. A subsample (n = 299) also had MRI‐based hippocampal volume data (ASHS segmentation). The outcomes of interest were A: Aβ42/40, T: p‐tau181, and N: hippocampal volume. Predictors included demographics and neuroinflammation markers. First, we tested the effect of sex and neuroinflammation markers on A, T, and N in the whole sample. Then, we tested the neuroinflammation*Aβ42/40 and neuroinflammation*p‐tau interactions on p‐tau and hippocampal volume, respectively. Finally, we looked at sex‐stratified models.Result: Men were older, more often APOE‐ε4 carriers and showed higher GFAP levels (men>women). In the whole sample, neither sex nor neuroinflammation markers were associated with Aβ42/40. However, sex (women>men), higher sTREM2 and higher YKL40 were associated with higher p‐tau181 levels, and sex (women<men), lower sTREM2, and higher YKL40 were associated with lower hippocampal volume. Models including interaction terms showed a sex‐independent interaction of GFAP with Aβ42/40 and p‐tau181 on p‐tau181 and hippocampal volume, respectively, suggesting a role of astrocytic activation along the ATN pathway. Sex‐stratified analyses showed (1) in women only, a YKL40*Aβ42/40 interaction on p‐tau181 and an association of higher sTREM2 levels with greater hippocampal volume (p = .030), suggesting a protective effect, and (2) in men only, a p‐tau181*sTREM2 and p‐tau181*YKL40 interaction on hippocampal volume. Statistics are provided in Table 1.Conclusion: Pending replication with longitudinal measurements, our results suggest that microglial and astrocytic activation may play a sex‐specific role in downstream amyloid. While astrocytic activation moderates the associations between A, T and N in men and women, microglial activation might provide resilience to neurodegeneration only in women (Figure 1).